MJFF $495K Grant to Help Move Alterity’s Potential Oral Therapy Into Trials

MJFF $495K Grant to Help Move Alterity’s Potential Oral Therapy Into Trials

286403

MJFF $495K Grant to Help Move Alterity’s Potential Oral Therapy Into Trials

Alterity Therapeutics has been awarded a grant from the Michael J. Fox Foundation (MJFF) for animal studies to determine the optimal dose its of lead candidate ATH434, an essential step to opening trials in people with Parkinson’s disease. “I look forward to seeing the results from the dose optimization studies for PD [Parkinson’s disease] clinical trials and future development in this indication,” Werner Poewe, MD, a professor of neurology at the Medical University Innsbruck, said…

You must be logged in to read/download the full post.